Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo.
about
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Ultrasound enhanced drug delivery to the brain and central nervous system.Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brainThe mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice.Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primates.Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome.Emerging non-cancer applications of therapeutic ultrasound.Fluid Viscosity Affects the Fragmentation and Inertial Cavitation Threshold of Lipid-Encapsulated MicrobubblesCharacterizing Focused-Ultrasound Mediated Drug Delivery to the Heterogeneous Primate Brain In Vivo with Acoustic Monitoring.Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood--brain barrier opening in vivo.Blood-Brain Barrier Opening in Behaving Non-Human Primates via Focused Ultrasound with Systemically Administered MicrobubblesNeuromodulation accompanying focused ultrasound-induced blood-brain barrier opening.Therapeutic strategies to improve drug delivery across the blood-brain barrier.Transcranial cavitation detection in primates during blood-brain barrier opening--a performance assessment study.Drug delivery across the blood-brain barrier using focused ultrasound.First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound.Microbubble type and distribution dependence of focused ultrasound-induced blood-brain barrier openingTargeted delivery of erythropoietin by transcranial focused ultrasound for neuroprotection against ischemia/reperfusion-induced neuronal injury: a long-term and short-term study.Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles.Optimization of the ultrasound-induced blood-brain barrier openingStrategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound.Treatment of Movement Disorders With Focused Ultrasound.Distinct patterns of cerebral extravasation by Evans blue and sodium fluorescein in ratsClinical pharmacokinetics of antibacterials in cerebrospinal fluid.Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy.Delivery of therapeutic peptides and proteins to the CNS.Antivascular ultrasound therapy: magnetic resonance imaging validation and activation of the immune response in murine melanoma.Comparative in vitro studies of MR imaging probes for metabotropic glutamate subtype-5 receptor targeting.Focused ultrasound: tumor ablation and its potential to enhance immunological therapy to cancer.Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery.Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting.Targeting Effects on the Volume of the Focused Ultrasound-Induced Blood-Brain Barrier Opening in Nonhuman Primates In Vivo.Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease.Pharmacokinetic analysis and drug delivery efficiency of the focused ultrasound-induced blood-brain barrier opening in non-human primates.Diffuse Intrinsic Pontine Glioma : Clinical Features, Molecular Genetics, and Novel Targeted Therapeutics.Efficient Blood-Brain Barrier Opening in Primates with Neuronavigation-Guided Ultrasound and Real-Time Acoustic Mapping.Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
P2860
Q26778701-02698761-7810-4434-8D51-D219514CA46EQ26991618-D883D36C-A7B9-46D2-A547-B17E15D9FCE9Q27331875-95DEE321-4F85-42B6-9481-3019C07D3436Q28253117-F2ECBA94-16CC-4669-84F4-B18F706DDCCFQ28539271-A455325D-7133-4136-B959-D375BCAB51F1Q28539506-F9A54969-148C-4B82-B701-AE5E1E2A47EEQ30359285-3A722ED8-C947-45E5-8BB3-57A8A49D939FQ30361688-93A0DBD0-73ED-4588-9D4E-846C9C638BBDQ30362514-BDB353B4-D3F4-4D25-8C84-86E813250C61Q30369301-58CD409E-B500-4B0B-A864-6631F13B7CDDQ30387126-1ABE9D93-3B79-4E4A-B9B8-F8DA7A35DE36Q30400270-C95F1F5A-CCFB-4768-82CA-F3D7D209C9BDQ30400282-B933AF25-0817-46ED-842F-CB5B15E0D4BEQ30407443-B2F895B5-AD30-4D44-B992-DC6806CF96C4Q30410243-9424EC16-A35B-495A-BE2C-7211B342520DQ30414698-02876A72-4435-4FFA-9A29-89BB4549E78BQ30418996-3FECDE37-80F3-47B3-B839-1F900153937CQ30422150-B5302DAB-383A-4250-908A-A7D26BD93435Q30442104-ABFAD010-BC63-4C4A-8E4B-810FE2FB3F62Q30443197-336D1405-8267-4FE8-9DE3-99C0224678ADQ30458489-BF31EBD1-CA7B-4104-9523-0C2D2D36B32DQ30768284-B8DAA676-C59C-451B-83FC-A57BCDAB5A6AQ31048620-C027BB45-5BAC-4B5E-A7D0-98CDEEE099B9Q33773385-D95A4024-0234-4AFF-8C4B-5ADE0DCF5AD1Q34827819-C624371E-C368-4063-B8D6-E7F381CEAFA6Q38100704-E71CD60A-C2F3-4EA4-93A8-5F37D55D0E2CQ38135276-E97E3EB6-233B-43FD-A493-643421FE14CCQ38259307-895D15F7-5E7F-4E37-A163-4A6887BED565Q38917219-EBFE10BF-740C-4022-A6AA-3BB6F74EE38BQ39113752-615A6AE7-A434-4483-82BD-2A58F1A44170Q45073772-18ED8BAE-0FE2-4D9D-8F2A-D9933E606A7CQ47232453-6572122F-5F48-4381-BB88-05CAC72502DFQ47352783-4AC6B207-A997-4180-951B-B2CCCCA0EF15Q47408666-92E1F8F1-5764-40F0-AF1C-5E7B070D19E8Q48255390-813D4092-628E-4458-83C7-1028ACE6361CQ48288474-E92D1ACE-682C-433D-915A-E0B2A6061802Q48406848-E60F0B44-5E2D-48C6-8AF5-5B6C2D3B1D70Q55285428-AD13A921-13AC-41E3-A0F2-E4AD5642C00EQ55287105-6DFE482F-F178-4851-914E-0D2FE7AF2C55Q55456554-A7B2A7B5-9738-49D0-98B5-30F63692062A
P2860
Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Noninvasive, transient and sel ...... in non-human primates in vivo.
@ast
Noninvasive, transient and sel ...... in non-human primates in vivo.
@en
type
label
Noninvasive, transient and sel ...... in non-human primates in vivo.
@ast
Noninvasive, transient and sel ...... in non-human primates in vivo.
@en
prefLabel
Noninvasive, transient and sel ...... in non-human primates in vivo.
@ast
Noninvasive, transient and sel ...... in non-human primates in vivo.
@en
P2860
P50
P1433
P1476
Noninvasive, transient and sel ...... in non-human primates in vivo
@en
P2093
Fabrice Marquet
Yao-Sheng Tung
P2860
P304
P356
10.1371/JOURNAL.PONE.0022598
P407
P577
2011-07-22T00:00:00Z